Future Prospects of Vaccine Industry Remain Promising with Growth of Preventive Vaccines Market

Preventive Vaccines Market

 

Market Overview:

The Preventive Vaccines Market is estimated to be valued at US$ 42,660.2 Mn in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Preventive vaccines are biological therapeutics administered to humans and animals to prevent infectious diseases. They help boost immunity against specific infectious agents like bacteria and viruses.

Market Dynamics:
The growth of the preventive vaccines market will be driven by increasing awareness about vaccine-preventable diseases and government initiatives to promote immunization programs. According to WHO, vaccination prevents 2-3 million deaths each year globally. Various awareness campaigns by governments and NGOs educate people about benefits of vaccination. In addition, availability of government-funded vaccination programs ensure immunization of all sections of the society irrespective of their ability to pay. For instance, under the Universal Immunization Program of India, vaccines are provided freely to all children up to 12 years of age. Such initiatives are expected to increase the demand for preventive vaccines over the forecast period.

Market key trends:
One of the key trends in the preventive vaccines market is the development of combination vaccines. Combination or multivalent vaccines provide protection against multiple infectious diseases with a single vaccine administration. This helps in reducing the disease burden as well as the number of injections, thereby improving patient compliance. Rising adoption of combination vaccines is expected to drive the growth of the preventive vaccines market during the forecast period.

SWOT Analysis
Strengths: Wide product portfolio and strong brand image of key players like Sanofi, Pfizer and GSK. These companies offer varied vaccine products for different disease indications.
Weaknesses: High R&D costs associated with development of new vaccines. Vaccine development process is complex and lengthy involving extensive clinical trials.
Opportunities: Emergence of new diseases drives the need for novel vaccines. Growing immunization programs in developing countries also open up new opportunities.
Threats: Stringent regulatory approvals and recalls poses threats. Outbreaks of diseases may impact sales of existing vaccines.

Key Takeaways
The Global Preventive Vaccines Market Demand was valued at US$ 42,660.2 Mn in 2021 and is expected to reach US$ 76,098.5 Mn by 2028, expanding at a CAGR of 9.4% during the forecast period. The market is driven by increasing government focus on immunization programs aimed at preventing various infectious diseases.

Regional analysis:
North America dominated the global preventive vaccines market in 2021 and is expected to continue its dominance over the forecast period. This is attributed to high immunization rates backed by strong regulatory support and availability of advanced vaccines in the region. Asia Pacific is expected to exhibit the fastest growth over 2022-2028 due to large population base, improving access to vaccines, and growing healthcare expenditure in the region.

Key players:
Key players operating in the preventive vaccines market are Sanofi SA, Pfizer Inc., Novavax Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., AstraZeneca, and Takeda Pharmaceutical Company Limited, among others. These players are focusing on new product launches and expansion of manufacturing facilities especially in high growth emerging markets to strengthen their market position.

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more